// company-profile

Keros Therapeutics, Inc.

KROSExchange: NasdaqSector: Pharmaceutical PreparationsFilings: 55Insiders: 29

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares (net $12K). Buying was led by BIENAIME JEAN JACQUES.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 15, 2026BIENAIME JEAN JACQUESKROSPurchase1,000$11.70$12K
Apr 2, 2026Seehra JasbirKROSOption Exercise55,000$0.30$17K
Apr 2, 2026Seehra JasbirKROSOption Exercise55,000$0.00$0K
Mar 9, 2026Newton Charles W.KROSAward14,788$0.00$0K
Mar 9, 2026BIENAIME JEAN JACQUESKROSPurchase2,000$11.21$22K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →